MAUREEN WALLACE: Open Payments
NPI 1073559399 · SHOW LOW, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 40 payments from 21 companies in 2025. Trend: 2023 $864 · 2024 $892 · 2025 $1,015
Food & beverage: $915Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $146 |
| GlaxoSmithKline, LLC. | 5 | $115 |
| SEAGEN INC. | 1 | $100 |
| Celgene Corporation | 3 | $82 |
| PFIZER INC. | 4 | $77 |
| SOBI, INC | 2 | $56 |
| Incyte Corporation | 2 | $55 |
| ABBVIE INC. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| JAZZ PHARMACEUTICALS INC. | 1 | $36 |
Products named: OJJAARA, Doptelet, REBLOZYL, EPKINLY, XTANDI, Nubeqa, ZEPZELCA, POMALYST.
Industry payments across AZ — which companies pay providers there.
